As of 11:49am ET
| +0.05 / +3.40%|
The 2 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 4.90, with a high estimate of 5.80 and a low estimate of 4.00. The median estimate represents a +222.37% increase from the last price of 1.52.
The current consensus among 2 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.